Sepsis News and Research

Latest Sepsis News and Research

Annexin A5 protein may have therapeutic potential for treatment of sepsis

Sepsis is the leading cause of in-hospital death and there is no specific treatment for it. Now, research led by Dr. Qingping Feng of Western University (London, Canada) suggests a protein called recombinant human annexin A5 may have therapeutic potential for the treatment of this disease. The paper is published in advance, online in Critical Care Medicine.

15 Nov 2013

Severe sepsis mortality rates decrease over the past 20 years

A recent study from Boston University School of Medicine and Boston Medical Center shows a significant decrease in severe sepsis mortality rates over the past 20 years. Looking at data from patients with severe sepsis enrolled in clinical trials, researchers found that in-hospital mortality rates decreased from 47 percent between 1991 and 1995 to 29 percent between 2006 and 2009, a time period when no new pharmacological treatments were developed for severe sepsis.

14 Nov 2013

UTHealth to host intensive two-week course on critical care

An intensive two-week course on critical care will be hosted by the Department of Emergency Medicine at The University of Texas Health Science Center at Houston Medical School.

8 Nov 2013

Interaction between fat cells and bacterial toxins can lead to chronic inflammation

Making fat cells immortal might seem like a bad idea to most people, but for a team of University of Iowa scientists it was the ideal way to study how the interaction between bacteria and fat cells might contribute to diabetes.

31 Oct 2013

Powerful neodymium magnets cause 'significant' increase in pediatric ingestion-related injuries

The continued sale and availability of powerful, neodymium magnets-typically 10 to 20 times stronger than traditional magnets- are causing an increase in pediatric ingestion-related injuries, according to an abstract presented Sunday, Oct. 27, at the American Academy of Pediatrics National Conference and Exhibition in Orlando.

28 Oct 2013

ASN strongly recommends all adults to undergo routine screening for chronic kidney disease

The American Society of Nephrology strongly recommends that all adults undergo routine screening for chronic kidney disease (CKD), the 8th leading cause of death in the U.S. This contradicts screening guidelines recently released by the American College of Physicians (ACP).

23 Oct 2013

EvergreenHealth named one of America's 100 Best Hospitals in three specialty areas

EvergreenHealth today announced it has earned several distinctions for 2014 across many of the health care system's specialties from Healthgrades, the nation's leading independent provider of information to help consumers make informed decisions about a physician or hospital.

23 Oct 2013

FDA approves Cimzia for treatment of adults with active ankylosing spondylitis

UCB announced today that the U.S. Food and Drug Administration has approved Cimzia (certolizumab pegol) for the treatment of adults with active ankylosing spondylitis.

18 Oct 2013

King's College researchers identify new biomarker that detects sepsis in blood

Researchers at King's College London have identified a biomarker - a biological 'fingerprint' - for sepsis in the blood, and showed it could be possible to diagnose the condition within two hours by screening for this biomarker at a patient's bedside.

17 Oct 2013

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation , today announced the results of the MPACT phase III clinical trial of ABRAXANE® in combination with gemcitabine were published online in the October 16th edition of the New England Journal of Medicine.

17 Oct 2013

Ticagrelor drug may reduce risk of dying following heart attack

Scientists from the University of Sheffield have discovered ground breaking clues as to how the pioneering heart drug ticagrelor might reduce the risk of dying following a heart attack, in comparison to previous standard treatments.

16 Oct 2013

Research finding may help patients to better survive severe infectious diseases

Scientists of Charité - Universitätsmedizin Berlin for the first time have solved the 3-dimensional structure of the protein LBP and it´s genetic variant. This finding may help certain patients to better survive severe infectious diseases. The results have been published in the recent issue of the journal Immunity.

15 Oct 2013

Study compares effects of 2 intravenous fluids on survival for critically ill patients in ICU

Djillali Annane, M.D., Ph.D., of Raymond Poincare Hospital, Garches, France, and colleagues conducted a study to compare the effects of 2 types of intravenous fluids on survival for critically ill patients in an intensive care unit.

11 Oct 2013

Finding highlights new ways of treating inflammation disorders

A team led by scientists at The Scripps Research Institute (TSRI) has identified key signaling proteins in the inflammation process that contribute to the development of inflammatory diseases such as rheumatoid arthritis, psoriasis, sepsis and inflammatory bowel diseases.

11 Oct 2013

Hyperglycemia heightens pneumonia risk in pediatric burns patients

Research indicates that hyperglycemia puts pediatric burns patients at increased risk for pneumonia.

8 Oct 2013

Researchers identify protein that triggers inflammation in patients with hemorrhage, sepsis

Investigators at The Feinstein Institute for Medical Research have discovered a protein in the human body that can trigger and mediate inflammation in patients suffering from hemorrhage and sepsis. The findings were published in the online version of Nature Medicine on October 6, 2013.

7 Oct 2013

Antimicrobial usage causes vancomycin-resistant enterococci outbreaks in Greek NICU

Administration of antibiotics may have caused successive outbreaks of vancomycin-resistant enterococci in a Greek neonatal intensive care unit, according to a study in the October issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology.

2 Oct 2013

FDA approves Cimzia (certolizumab pegol) for active psoriatic arthritis

UCB announced today that the U.S. Food and Drug Administration has approved Cimzia (certolizumab pegol) for the treatment of adult patients with active psoriatic arthritis.

30 Sep 2013

Study shows need for improved detection of sepsis for all women in labor

Rates of severe sepsis and deaths from sepsis among U.S. women hospitalized for delivery have risen sharply over the last decade, reports a study in the October issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

24 Sep 2013

Fingerstick blood sample test using i-STAT device not accurate in determining troponin level: Study

Researchers have determined that fingerstick cardiac troponin I assay testing using thepoint-of-care i-STAT device is not accurate enough to determine the exact troponin level without the application of a corrective term.

21 Sep 2013

Sepsis News and Research

Latest Sepsis News and Research

Annexin A5 protein may have therapeutic potential for treatment of sepsis

Severe sepsis mortality rates decrease over the past 20 years

UTHealth to host intensive two-week course on critical care

Interaction between fat cells and bacterial toxins can lead to chronic inflammation

Powerful neodymium magnets cause 'significant' increase in pediatric ingestion-related injuries

ASN strongly recommends all adults to undergo routine screening for chronic kidney disease

EvergreenHealth named one of America's 100 Best Hospitals in three specialty areas

FDA approves Cimzia for treatment of adults with active ankylosing spondylitis

King's College researchers identify new biomarker that detects sepsis in blood

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

Ticagrelor drug may reduce risk of dying following heart attack

Research finding may help patients to better survive severe infectious diseases

Study compares effects of 2 intravenous fluids on survival for critically ill patients in ICU

Finding highlights new ways of treating inflammation disorders

Hyperglycemia heightens pneumonia risk in pediatric burns patients

Researchers identify protein that triggers inflammation in patients with hemorrhage, sepsis

Antimicrobial usage causes vancomycin-resistant enterococci outbreaks in Greek NICU

FDA approves Cimzia (certolizumab pegol) for active psoriatic arthritis

Study shows need for improved detection of sepsis for all women in labor

Fingerstick blood sample test using i-STAT device not accurate in determining troponin level: Study

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Sepsis News and Research

Latest Sepsis News and Research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Newsletters you may be interested in